Press Release

OmniSeq collaborates with UPMC to employ its RNA sequencing (RNA-seq) gene expression profile assay for selecting cancer immunotherapy combinations

rna-seq

OmniSeq®, an innovator in next generation sequencing in oncology, today announced its collaboration with the University of Pittsburgh Medical Center (UPMC) to employ its RNA sequencing (RNA-seq) gene expression profile assay for selecting immunotherapy combinations for patients in a Phase II clinical ...

Read More »